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Aromatic hydroxylated compounds are ubiquitous in nature and are extensively used in the 
chemical and pharmaceutical industries. These compounds may act as antioxidants in human cells, 
preventing degenerative diseases caused by free radicals, such as cancer, heart disease and immune 
system decline. 
 The chemical synthesis of hydroxylated aromatic compounds is often hampered by severe reaction 
conditions, resulting in low yields and the formation of racemic mixtures. Thus, growing attention 
has been dedicated in the last years to the development of biotransformations, such as those 
catalyzed by Bacterial Multicomponent Monooxygenases (BMM). 
 In this work, the BMM ToMO from Pseudomonas sp. OX1, recombinantly expressed in whole 
cells of E.coli, strain JM109, was used for the production of novel hydroxylated aromatic 
compounds starting from commercially available precursors such as 2-phenoxyethanol, 2-indanol 
and phtalan. Both substituted phenols and catechols were obtained which were purified on HPLC, 
and identified by NMR and mass spectrometry analysis. The antioxidant potential of our novel 
hydroxylated compounds was assessed both in vitro, by using the DPPH chemical assay, and ex 
vivo on the cardiomyoblast cell line H9c2 subjected to a mild oxidative stress induced by sodium 
arsenite.  
Not all compounds showed antioxidant activity in the DPPH assay; however, all compounds 
showed a differential protective effect on cells subjected to the mild oxidative stress. Our results 
highlight the potential of our novel compounds as antioxidant molecules that can be functionalized 
in the near future to obtain a wide array of new molecules for the pharmaceutical industry.  
